Screener
Capricor Therapeutics CAPR Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
FAQ
- What is Capricor Therapeutics's asset turnover?
- Capricor Therapeutics (CAPR) reported asset turnover of 0× in Q4 2025.
- How has Capricor Therapeutics's asset turnover changed year-over-year?
- Capricor Therapeutics's asset turnover decreased by 100.0% year-over-year, from 0.2× to 0×.
- What is the long-term trend for Capricor Therapeutics's asset turnover?
- Over 3 years (2020 to 2025), Capricor Therapeutics's asset turnover has grown at a -100.0% compound annual growth rate (CAGR), from 0× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Capricor Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude